FDA Approved: EMFLAZA — Original Application (PTC Therapeutics, Inc.)

View source ↗

Summary

The FDA approved EMFLAZA (deflazacort) from PTC Therapeutics via original NDA for the treatment of Duchenne muscular dystrophy in patients aged 2 years and olde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• EMFLAZA (deflazacort)

Snippet

ORIG AP for EMFLAZA (DEFLAZACORT)